Poland· PL-100119270
Milgamma N
A vitamin b1, vitamin b6 und vitamin b12 product containing thiamini hydrochloridum + pyridoxini hydrochloridum + cyanocobalaminum, registered in Poland by Woerwag Pharma GmbH & Co. KG.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Thiamini hydrochloridum + Pyridoxini hydrochloridum + Cyanocobalaminum
- Manufacturer
- Woerwag Pharma GmbH & Co. KG
- Country
- Poland (PL)
- ATC code
- A11DB03
- ATC class
- Vitamin B1, Vitamin B6 und Vitamin B12
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991020415
- gtin05909991020422
- gtin05909991020439
- gtin05909991020446
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vitamin b1, vitamin b6 und vitamin b12 in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEUROMAX FORTEVitabalans OY, Hämeenlinna
- SwitzerlandBenexol B12, FilmtablettenBayer (Schweiz) AG
- SpainANTINEURINA AMPOLLASMabo Farma S.A.
- FinlandNeurobion NMerck KGaA
- GermanyMilgamma NWörwag Pharma Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Citoneurin, Neurobion
- Belgium · Neurobion
- Bulgaria · Бевит Форте
- Cyprus · Betrimine
- Czechia · Neuromax Forte, Neuromultivit
- Germany · Milgamma N, Neurobion Zur Anwendung Bei Erwachsenen
- Estonia · Neuromax Forte, Neuromultivit
- Spain · Benexol, Hidroxil
- Finland · Neuromax Forte
- Greece · 3be, Be Union
- Hungary · Milgamma N, Neurogerlon
- Italy · Benexol
- Lithuania · Anoveb, Milgamma N
- Latvia · Milgamma N Injekt, Neuromax Forte
- Malta · Neuromultivit
- Portugal · Becorion, Associação, Neurobion, Associação
- Romania · Neuromultivit
- Slovakia · Neuromultivit
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff318f55-cc6d-437d-a557-f03560328978 GET /v1/drugs/ff318f55-cc6d-437d-a557-f03560328978?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań domięśniowych",
"source": "urpl",
"strength": "(50 mg + 50 mg + 0,5 mg)/ml",
"packaging": "05909991020415 ¦ Rp ¦ 22230\n5 amp. 2 ml\n05909991020422 ¦ Rp ¦ 22231\n25 amp. 2 ml\n05909991020439 ¦ Rp ¦ 22232\n100 amp. 2 ml\n05909991020446 ¦ Rp ¦ 61843\n500 amp. 2 ml",
"substance": "Thiamini hydrochloridum (vitaminum B1) 50 mg/ml + Pyridoxini hydrochloridum (Vitaminum B6) 50 mg/ml + Cyanocobalaminum (Vitaminum B12) 0,5 mg/ml",
"common_name": "Thiamini hydrochloridum + Pyridoxini hydrochloridum + Cyanocobalaminum",
"pl_product_id": "100119270",
"pozwolenie_nr": "10204",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about vitamin b1, vitamin b6 und vitamin b12.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.